|Bid||28.30 x 3200|
|Ask||28.34 x 800|
|Day's Range||27.04 - 28.50|
|52 Week Range||20.03 - 54.97|
|Beta (5Y Monthly)||0.94|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov. 03, 2020 - Nov. 09, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||61.00|
Ken Mills became the CEO of REGENXBIO Inc. (NASDAQ:RGNX) in 2009, and we think it's a good time to look at the...
Regenxbio (RGNX) delivered earnings and revenue surprises of -2.25% and -14.56%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Regenxbio (RGNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.